Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

VNDA – vanda pharmaceuticals inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VNDA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
08:00 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Report
12/20
09:33 am
vnda
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera [Yahoo! Finance]
Low Report
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera [Yahoo! Finance]
Report
12/20
09:13 am
vnda
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera
Medium Report
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera
Report
12/19
02:12 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
12/16
09:29 pm
vnda
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
Low Report
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
Report
12/11
02:03 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
12/3
03:32 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/25
03:38 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/17
03:02 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/14
07:26 am
vnda
New Strong Buy Stocks for November 14th [Yahoo! Finance]
Medium Report
New Strong Buy Stocks for November 14th [Yahoo! Finance]
Report
11/12
05:10 pm
vnda
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences [Yahoo! Finance]
Low Report
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences [Yahoo! Finance]
Report
11/12
04:58 pm
vnda
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
Low Report
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
Report
11/9
02:07 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/9
02:07 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
11/7
02:31 am
vnda
Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ... [Yahoo! Finance]
Low Report
Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ... [Yahoo! Finance]
Report
11/6
05:19 pm
vnda
Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium Report
Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Report
11/6
04:02 pm
vnda
Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results
Low Report
Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results
Report
11/5
08:44 am
vnda
Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks [Yahoo! Finance]
Low Report
Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks [Yahoo! Finance]
Report
11/4
04:45 pm
vnda
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Low Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Report
11/2
11:00 am
vnda
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Medium Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Report
11/1
02:07 pm
vnda
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst [Yahoo! Finance]
Low Report
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst [Yahoo! Finance]
Report
11/1
02:06 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Report
10/31
08:00 pm
vnda
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Medium Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA
Report
10/31
07:36 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.
Low Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.
Report
10/30
04:30 pm
vnda
Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
Low Report
Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2024, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0